FAT10 is the only ubiquitin-like modifier that can target proteins for degradation by the proteasome in a ubiquitin-independent manner. The degradation of FAT10-linked proteins by the proteasome is strongly accelerated by the ubiquitin-like-ubiquitin-associated protein nEDD8 ultimate buster-1 long (nuB1L). Here we show how FAT10 and nuB1L dock with the 26s proteasome to initiate proteolysis. We identify the 26s proteasome subunit hRpn10/s5a as the receptor for FAT10, whereas nuB1L can bind to both Rpn10 and Rpn1/s2. unexpectedly, FAT10 and nuB1L both interact with hRpn10 via the VWA domain. FAT10 degradation in yeast shows that human Rpn10 can functionally reconstitute Rpn10-deficient yeast and that the VWA domain of hRpn10 suffices to enable FAT10 degradation. Depletion of hRpn10 causes an accumulation of FAT10-conjugates also in human cells. In conclusion, we identify the VWA domain of hRpn10 as a receptor for ubiquitin-like proteins within the 26s proteasome and elucidate how FAT10 mediates efficient proteolysis by the proteasome.
Results

19S RP subunits interacting with FAT10 and NUB1L.
To identify the subunit(s) within the 19S RP that mediate FAT10 and NUB1L binding to the proteasome, interaction of each individual 19S RP subunit with FAT10 and NUB1L was analysed in a yeast two-hybrid assay. hRpn10 was the only subunit for which an interaction with FAT10 could be detected (Fig. 1a) . hRpn10 also interacted with NUB1L (Fig. 1b) , confirming this previously described interaction 33 . The previously established interaction of FAT10 with NUB1L was used as a positive control 32 . Taken together, these results suggest that FAT10 and NUB1L binding to the proteasome occurs via a common 19S RP subunit, hRpn10. FAT10 binds to hRpn10 and NUB1L to hRpn10 and hRpn1. To test whether the interactions of FAT10 and NUB1L with hRpn10 can be attributed to a direct binding of the proteins, glutathione S-transferase (GST)-pull-down experiments were performed. HishRpn10 showed specific binding to GST-FAT10 and GST-NUB1L, but not to the GST control (Fig. 2a) confirming a direct interaction of FAT10 and NUB1L with hRpn10. Moreover, we also found specific binding of the yeast Rpn10 protein (scRpn10) to GST-FAT10 and GST-NUB1L (Fig. 2b) .
Recently, it was shown that a conserved amino-terminal region of Rpn13, the Pru domain, binds to ubiquitin and also binds to UBL domains of UBL-UBA proteins like hHR23a and hPLIC2 (ref. 4) . Although FAT10 failed to bind to the Pru domain of Rpn13 in an earlier study 4 , we re-investigated this possibility with full-length hRpn13 
s2/Rpn1, (3) s3/Rpn3, (4) s4/Rpt2, (5) s5a/Rpn10, (6) s5b, (7) s6a/Rpt5, (8) s6b/Rpt3, (9) s7/Rpt1, (10) s8/Rpt6, (11) s9/Rpn6, (12) s10a/Rpn7, (13) s10b/Rpt4, (14) s11/Rpn9, (15) s12/Rpn8, (16) s13/ Rpn11, (17) s14/Rpn12, (18) s15, (19) p55/Rpn5. (20) As positive control, we co-transformed the nmY51 cells with pGADT7-nuB1L and pLexA-FAT10. A second positive control (21) was the known interaction of nuB1L and hRpn10. Transformants were grown on selection plates containing 3-AT but lacking tryptophan and leucine ( − TL) or tryptophan, leucine and histidine ( − TLH), respectively (upper and middle panels). Confirmation of these results was obtained by X-gal filter assay (lower panel). The experiments have been repeated twice with similar outcomes. (b) Yeast two-hybrid analysis of the interaction of nuB1L with individual subunits of the human 19s RP. The yeast two-hybrid analysis was performed as in (a) except that plasmid pGADT7-nuB1L was used instead of pGADT7-FAT10.
in GST-pull-down assay, and we likewise observed that hRpn13-myc was pulled down neither by GST-FAT10 nor GST-NUB1L. Taking into consideration that the UBL domain of Rad23 and Dsk2 interact with the leucine-rich-repeat-like domain of the Rpn1 subunit of the 19S RP 35 , we hypothesized that FAT10 or NUB1L might also interact with hRpn1. Binding assays with recombinant GST-FAT10, GST-NUB1L or GST alone and radiolabelled in vitro translated His-hRpn1 were carried out. Remarkably, His-hRpn1 bound robustly to GST-NUB1L but did not bind to GST-FAT10 or GST alone (Fig. 2c) .
To test whether NUB1L binding to hRpn1 depended on the UBL domain or the two UBA domains of NUB1L, GST-pull-down experiments with NUB1L-deletion variants were carried out. The deletion of the UBL domain (GST-NUB1L∆UBL) resulted in a strong reduction of His-hRpn1 binding (Fig. 2d) indicating a pivotal role of the UBL domain of NUB1L in the binding of His-hRpn1. Moreover, we also investigated whether the UBL domain of NUB1L is essential for the interaction with hRpn10 and, as observed in GST-pulldown assays, the interaction was very weak, if the UBL domain was missing as compared with the interaction when the UBA domains were missing (Fig. 2d) . Together, our data show that NUB1L binds to hRpn1 and hRpn10 predominantly via its UBL domain.
The C-terminal UBL domain of FAT10 interacts with hRpn10. FAT10 consists of two ubiquitin-like domains ( Supplementary  Fig. S1 ) 20 . To determine which FAT10 domain interacts with hRpn10, recombinant His-Rpn10 was incubated with lysates from HEK293T cells transiently transfected with the plasmid carrying HA-FAT10-GFP, HA-N-FAT10-GFP, HA-C-FAT10-GFP, HA-Ub-GFP, and GFP alone. Interestingly, only the C-terminal UBL domain of FAT10 bound to hRpn10 but not the N-terminal UBL of FAT10 (Fig. 2e) ; full-length HA-FAT10-GFP served as a positive control and HA-Ub-GFP as well as GFP alone did not show any binding to hRpn10 that served as negative controls. Thus, the N-terminal UBL domain of FAT10 binds to NUB1L 34 , whereas the C-terminal UBL domain binds to hRpn10.
FAT10 and NUB1L interact with the VWA domain of hRpn10. As mentioned above, human Rpn10 contains three domains, the VWA domain and two ubiquitin interacting motifs (UIM1 and UIM2). The UIMs are binding sites for polyubiquitin chains 9, 11 . To identify the domain within the hRpn10 protein mediating FAT10 and NUB1L binding, GST-pull down assays were performed. In vitro translated full-length His-hRpn10 as well as the His-tagged VWA domain alone (His-VWA) bound to GST-FAT10 and GST-NUB1L, whereas His-hRpn1 (10% of input)
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no binding was detectable for the two UIMs of hRpn10 (Fig. 2f) . Polyubiquitin chains bind preferably to UIM2 and to a lesser extent to UIM1 (ref. 12). The amino-acid sequence motifs crucial for the binding of polyubiquitin to UIM1 and UIM2 are designated LALAL and IAYAM, respectively 12 . To corroborate the above finding, we performed the same experiment with full-length hRpn10 bearing a mutated LALAL motif in UIM1 (mutated to AAAAA) and a mutated IAYAM motif in UIM2 (mutated to AAAAA; hereafter referred to as mutated UIMs) and observed that FAT10 and NUB1L can still interact with these mutated proteins (Fig. 2f) .
On comparing the amino-acid sequences of FAT10 and ubiquitin, we realized that the key residues within ubiquitin required for binding to the hRpn10 UIM domains, Leu8, Ile44 and Val70 neither align with FAT10's N-terminal nor its C-terminal UBL domain ( Supplementary Fig. S1 ). This observation is in accordance with separate binding sites for FAT10 and ubiquitin within hRpn10. Collectively, our results show that FAT10 and NUB1L bind to the VWA domain of hRpn10 in contrast to polyubiquitin chains that bind to the UIM domains of hRpn10.
Rescue of Rpn10∆ yeast with human Rpn10 or the VWA domain. The role of hRpn10, in particular that of its VWA domain, in the degradation of FAT10 was investigated in Saccharomyces cerevisiae as Rpn10-deficient yeast is viable. We tested whether hRpn10 can functionally substitute for scRpn10 in S. cerevisiae. Yeast cells lacking Rpn10 (rpn10∆) show a pronounced sensitivity towards canavanine 3 . Canavanine is an arginine analogue causing misfolding of proteins that are targeted for proteasomal degradation. Consistent with an earlier study 3 , N-terminally FLAG-tagged scRpn10 expressed from a high-copy plasmid lead to a suppression of the canavanine sensitivity of rpn10∆ (NRY5) cells restoring WT-like growth on plates containing 3 µg ml − 1 canavanine, whereas the growth of rpn10∆ cells transformed with an empty plasmid was strongly retarded (Fig. 3 ). In the same experiment, rpn10∆ cells transformed with the FLAG-hRpn10 expression construct showed growth on a canavanine containing plate comparable to that of rpn10∆ cells reconstituted with scRpn10 ( Fig. 3) , indicating that hRpn10 can functionally substitute for scRpn10 in S. cerevisiae. Earlier studies demonstrated that the rpn10-uim mutant or the VWA domain of Rpn10 show wild-type level of sensitivity to canavanine 18, 36 . Whether the VWA domain of hRpn10 alone or hRpn10 with mutated UIMs would be able to suppress the canavanine sensitivity of rpn10∆ cells was tested. Interestingly, expression of both, the FLAG-tagged VWA domain as well as the hRpn10 with mutated UIMs, led to a partial suppression of the canavanine sensitivity (Fig. 3) indicating that the VWA domain alone is able to functionally reconstitute the Rpn10-deficient yeast proteasome.
FAT10 binds to the proteasome in wild-type but not rpn10∆ yeast.
A potential binding of FAT10 with proteasome-associated scRpn10 in yeast was further analysed by glycerol gradient centrifugation. Lysates of either WT or rpn10∆ cells expressing N-terminally HA-tagged FAT10 were separated by glycerol gradient centrifugation, and collected fractions were analysed by immunoblotting (Fig. 4a,b) . Free cytosolic Rpn10 was observed in low molecular weight fractions 1-4. Western blots probed with antipre6, anti-scRpn10, anti-Rpt1 antibodies showed the presence of 20S and 19S RP in fractions 10-16 and 10-15 in the wild-type and rpn10∆ strains, respectively. We could detect a very low level of RP-CP-RP complex in the fractions from the wild-type yeast (19) (20) but not in fractions from rpn10∆ yeast, which is in accordance with the previous studies, which showed the dissociation of lid and the base in the rpn10∆ yeast 6, 19 . The presence of pre6 and Rpt1 in the same fractions showed their existence in the form of a complex (probably RP-CP complex) in the rpn10∆ yeast strain as well. Aminopeptidase I (~600 kDa decamer, AP1) served as a size marker for fractions containing 20S proteasome. In the extract derived from WT cells, HA-FAT10 migrated in the lower and the higher molecular weight fractions (fractions 1-12 and 15-20; Fig. 4a ), whereas it was only found in the lower molecular weight fractions in extracts from cells lacking Rpn10 (fractions 1-8; Fig. 4b ), suggesting the association of FAT10 with proteasomeassociated Rpn10. The presence of 20S proteasome in these high molecular weight fractions (fractions 10-15) was further corroborated by the presence of hydrolytic activity towards the fluorogenic substrate Suc-LLVY-AMC (Fig. 4c) . The peptidase activity increased in the presence of 0.02% SDS indicating the presence of 20S proteasome, whereas the activity was almost abolished in the presence of the proteasome inhibitor MG132 (Fig. 4c) .
The VWA domain of hRpn10 is required for degradation of FAT10. As FAT10 was found to interact with the VWA domain of hRpn10 (Fig. 2f) , we investigated whether this interaction would have functional relevance for the degradation of FAT10 in vivo. The degradation rate of ectopically expressed HA-FAT10, in WT and rpn10∆ yeast cells, was determined by cycloheximide chase analysis. HA-FAT10 was readily degraded in WT cells with a half-life of ~2 h, whereas it was stable over the 6-h chase period in rpn10∆ cells (Fig. 5a ). HA-FAT10 degradation was almost completely restored in rpn10∆ cells on ectopic expression of either scRpn10 or hRpn10 (Fig. 5b) . Remarkably, expression of only the VWA domain was sufficient to restore degradation of HA-FAT10 in cells lacking Rpn10 (Fig. 5c) . Likewise, hRpn10 with mutated UIMs also restored HA-FAT10 degradation to WT-like levels.
NUB1L relies on hRpn10 for promoting the degradation of FAT10.
Because the degradation of FAT10 is accelerated by NUB1L 32 , and because both FAT10 and NUB1L interact with hRpn10, we investigated whether the stimulating effect of NUB1L on the degradation of FAT10 would depend on hRpn10 in vivo. Cycloheximide chase experiments were performed as described above, except that HA-NUB1L was also expressed in yeast cells. The HA-FAT10 protein remained stable in rpn10∆ yeast cells even in the presence of HA-NUB1L, but its degradation was accelerated in wild-type cells (Fig. 5d) . Following reconstitution of HA-NUB1L expressing rpn10∆ cells with either FLAG-scRpn10 or FLAG-hRpn10, degradation rates similar to that of the WT strain expressing HA-NUB1L were observed ( Fig. 5e-g; Supplementary Fig. S2 ). The quantitative analysis revealed that the half-life of HA-FAT10 was reduced to less than 1 h (Fig. 5g) . Collectively, these results show that the accelerating effect of NUB1L on FAT10 degradation is dependent on hRpn10. Canavanine sensitivity plate growth assay with WT and rpn10∆ S. cerevisiae transformants. WT or rpn10∆ cells transformed with high-copy expression plasmids for FLAGscRpn10, FLAG-hRpn10, FLAG-VWA or FLAG-hRpn10-uIms mutated or with the empty plasmid were spotted on plates with synthetic medium lacking leucine (sD-Leu) or on plates lacking leucine and arginine that contain 3 µg ml − 1 canavanine. The growth assay has been repeated three times with similar results.
To confirm the earlier finding that the degradation of FAT10 is independent of ubiquitin 21, 22 , we analysed the degradation of lysine-deficient FAT10 in yeast and found it to be degraded as rapidly as WT FAT10 (Fig. 5h) . We noted that FLAG-hRpn10 or FLAG-VWA was also degraded over time (Fig. 5b,c) but this degradation occurred independently of HA-FAT10 (Fig. 5i) .
Degradation of FAT10 via hRpn10-VWA is proteasome-dependent. To determine whether FAT10 is degraded by the proteasome, we investigated whether FAT10 could be stabilized by MG132 (ref. 37 ). The pdr5 gene was disrupted in WT and rpn10∆ cells, as WT yeast cells readily export MG132 via the multi-drug transporter Pdr5 rendering them resistant to MG132. Cycloheximide chase experiments in the presence of MG132 were performed in pdr5∆ (NRY51) and pdr5∆rpn10∆ (NRY53) cells transformed with an expression plasmid for HA-FAT10 alone or in combination with an expression plasmid for FLAG-hRpn10 or FLAG-VWA. Strikingly, addition of MG132 led to a strong stabilization of FAT10 in all the transformants tested, even in the pdr5∆rpn10∆ strain reconstituted with only the VWA domain (Fig. 6a-c) . Additionally, the degradation of FAT10 was analysed in the proteasome mutant yeast strain pre1-1 (ref. 38) . Cycloheximide chase experiments were performed after transforming HA-FAT10 into pre1-1 and its parental strain. We observed the stabilization of FAT10 in pre1-1 strain as compared with the WT strain under non-permissive conditions (Fig. 6d) . Moreover, mutating the Asp11 residue in the VWA domain of human or yeast Rpn10 to Ala, which affects ubiquitin-mediated proteolysis by the 26S proteasome, also interferes with the degradation of FAT10 (Supplementary Fig. S3 ). Taken together, these data strongly suggests that the degradation of FAT10 is proteasome-dependent.
FAT10 competes with NUB1L for binding to hRpn10-VWA. As mentioned above, the N-terminal domain of FAT10 docks to NUB1L 34 , whereas the C-terminal domain of FAT10 docks to hRpn10 (Fig. 2e) . To investigate whether a trimeric complex is formed, GST-NUB1L∆UBL bound to glutathione-sepharose (reduced) beads was incubated with His-hRpn10 and FAT10 either in equimolar amount or with increasing concentrations. An increase in the binding of His-hRpn10 on the beads with the increasing concentrations of FAT10 was clearly observed (Fig. 7a) , which confirmed that FAT10 can bind to NUB1L and hRpn10 simultaneously using distinct domains.
As both FAT10 and NUB1L can bind to the VWA domain of hRpn10 (Fig. 2f) , we determined whether they can compete with each other for hRpn10 binding. To this aim, we utilized a deletion mutant of NUB1L lacking UBA domains, which cannot bind to FAT10 but still binds to hRpn10. Recombinant His-hRpn10 was bound to Ni-beads and recombinant GST-NUB1L∆UBA was incubated with these beads along with FAT10 at increasing concentrations. Interestingly, increasing levels of FAT10 molecules displaced NUB1L from hRpn10 (Fig. 7b) , which suggests that NUB1L and FAT10 bound to the same motif on the VWA domain implying that, Treatment with mG132 reduced the peptidase activity to basal level (filled circles), which confirmed that this activity relied on the proteasome. After addition of 0.02% sDs, the peptidase activity of 20s proteasome-containing fractions was increased (filled triangles). The unspecific background activity by the substrate was subtracted.
with an excess of FAT10, NUB1L is unable to bind to hRpn10 but can still bind to Rpn1.
hRpn10 knockdown in human cells causes FAT10 accumulation.
Contrary to yeast, mammalian cells deficient in hRpn10 are not viable over extended periods of time 39, 40 . Therefore, the function of hRpn10 in the degradation of FAT10 and its conjugates in mammalian cells was addressed by transiently knocking down hRpn10 with short interfering RNA (siRNA) in HEK293 cells that lead to extensive depletion of hRpn10 (Fig. 8a) but did not affect their viability during the course of the experiment. The steady-state level of monomeric FAT10, as well as FAT10 conjugates, was significantly increased in cells treated with hRpn10 siRNA as compared with cells treated with control siRNA (Fig. 8a,b) . In HEK293 cells stimulated with IFN-γ and TNF-α to induce endogenous FAT10 expression, there was no accumulation of FAT10 or FAT10 conjugates when normalized to β-actin expression (Fig. 8c) . However, realtime RT-PCR analysis revealed that treatment of cytokine-induced cells with hRpn10 siRNAs consistently reduced endogenous FAT10 messenger RNA levels by ~60% when compared with cells treated with control siRNA (Fig. 8d) . When we normalized the levels of monomeric or substrate-conjugated endogenous FAT10 protein on the level of FAT10 mRNA, we confirmed an accumulation of FAT10 and its conjugates after knockdown of hRpn10 (Fig. 8d) .
Recently, we have identified the ubiquitin-activating enzyme UBE1 as a substrate of FAT10ylation, and we tested whether the UBE1-FAT10 conjugate would accumulate in HEK293 cells upon hRpn10 knockdown. Depletion of hRpn10 led to a twofold increase in the amount of UBE1-FAT10 conjugate (Fig. 8e, f) . These results suggest that hRpn10 functions as a receptor for FAT10 and its conjugates and targets them for proteasomal degradation also in mammalian cells.
Discussion
Degradation of proteins by the proteasome is regulated at several levels. One level is the docking step to the 26S proteasome, which in the ubiquitin system, is mediated by binding of poly-ubiquitin chains to the proteasome subunits Rpn10 or Rpn13 or to soluble ubiquitin receptors, which in turn bind to Rpn1 or Rpn2 (ref. 1). Interestingly, these two binding modes seem to mutually affect each other, as the degradation of poly-ubiquitylated Sic1 at the isolated 26S proteasome via Rad23 was shown to be facilitated by binding of the VWA domain of the Rpn10 subunit to the proteasome 19 . Similar evidence regulating the pace of proteasomal degradation has been observed for the FAT10 system where NUB1L accelerated FAT10 degradation about eightfold 32 . This stimulating effect relied on the N-terminal UBL domain of NUB1L required for proteasome binding and was independent of the three UBA domains of NUB1L, which bind to FAT10 (ref. 34). FAT10, therefore, resembles ubiquitin in that it can bind directly to the proteasome or can become tethered to the proteasome via the UBL-UBA protein NUB1L. To better understand how NUB1L influences the rate of FAT10 degradation, we set out to identify the subunit(s) of the RP which bind to FAT10. Rpn10 was the only RP subunit found to interact with FAT10 in our yeast two-hybrid analysis. The finding that FAT10 and NUB1L bind to the same subunit raised the question how NUB1L may act as a facilitator of FAT10-mediated degradation. One possibility was that FAT10 and NUB1L bind to different domains of Rpn10. It was therefore surprising that both of them bound to the same domain. Even more surprising was that these two ubiquitin-like proteins did not bind to the UIM domains of Rpn10, like ubiquitin, but instead to the VWA domain, which seems to be a novel UBL-binding domain (Fig. 2f) . VWA domains contain a β-sheet sandwiched by multiple α-helices and they usually bind to metal ions via a metal ion-dependent adhesion site. It was hypothesized that the VWA domains mediate proteinprotein interactions involved in the assembly or function of multiprotein complexes 7, 36 . We have extensively tried to identify the residues within the VWA domain that are involved in FAT10-and NUB1L-binding by mutagenesis. However, several combined point mutations were unsuccessful in abolishing the binding to NUB1L or FAT10, whereas deletion variants could not be stably expressed.
The human Rpn10 subunit was able to reconstitute growth of rpn10∆ S. cerevisiae cells in canavanine sensitivity assays (Fig. 3) . Rpn10 is required to keep the base and the lid of the RP firmly associated 6, 19 and our transcomplementation data with human Rpn10 suggest that the human orthologue can serve this structural function also in the context of the yeast 26S proteasome. The reconstitution of Rpn10-deficient yeast with human Rpn10 encouraged us to test whether FAT10 degradation could be reconstituted in yeast. The reconstitution of FAT10 degradation in yeast seemed justified as Rpn10 has been shown to be essential in mouse cells 40 and is required for normal degradation of ubiquitin-conjugates in Drosophila 39 . We could show that FAT10 is degraded in yeast in a Rpn10-dependent manner (Fig. 5) . The fact that FAT10 degradation was supported by both yeast and human Rpn10 is consistent with the finding that not the UIMs (which differ in number between human and yeast), but the VWA domain of Rpn10 is required for FAT10 degradation. This system further allowed us to show that the VWA domain sufficed to robustly reconstitute FAT10 degradation (Fig. 5c) , which is in accordance with our binding studies (Fig. 2f) . Interestingly, the VWA domain could largely restore wild-type-like growth of Rpn10-deficient yeast on canavanine-containing plates (Fig. 3) . Consistently, mice bearing only a VWA domain survive longer than mice that completely lack mRpn10 (ref. 40) . The knockdown of hRpn10 in human HEK293 cells led to an accumulation of FLAG-FAT10 and endogenous FAT10 and bulk FAT10 conjugates (when normalized to the level of FAT10 mRNA), and the UBE1-FAT10 conjugate by 30-50% (Fig. 8) , suggesting that hRpn10 serves as a FAT10 receptor also in humans, although the effect was not as strong as found after rpn10 deletion in yeast. This difference is most likely due to residual hRpn10 protein in the siRNA-treated human cells.
Previously the only subunit known to interact with NUB1L was hRpn10 and it was shown that the C terminus of NUB1L binds to hRpn10 (ref. 33) . Another study reported that the association of NUB1L with the 26S proteasome occurs via the N-terminal UBL domain 34 . We show here that the UBL domain of NUB1L binds to hRpn1 as well as hRpn10 of the 26S proteasome in accordance with the latter report (Fig. 2d) . Interestingly, we could also show that the C-terminal UBL domain of FAT10 binds to hRpn10 (Fig. 2e) , which leaves the N-terminal UBL domain of FAT10 free for docking to the UBA domains of NUB1L 34 resulting in formation of a trimeric NUB1L-FAT10-Rpn10 complex (Fig 7a) .
One may speculate about the biological consequences of FAT10 being degraded slowly in the absence of NUB1L and faster in its presence. It is possible that different FAT10ylated substrates require different rates of proteasome-mediated degradation and that only those are bound by NUB1L, which require rapid degradation. A striking difference between ubiquitin and FAT10 is that ubiquitin is recycled with the help of numerous ubiquitin-deconjugating enzymes whereas such enzymes have not been found to date for FAT10 that seems to be degraded along with its substrates 21, 22 . The overexpression of FAT10 is toxic to cells 27 and it is possible that NUB1L contributes to keeping FAT10 at a low level.
The key findings of this study can be exploited to suggest two models for how NUB1L accelerates the degradation of FAT10. FAT10 might directly bind to the VWA domain of hRpn10 and become degraded at a slow rate in the absence of NUB1L (Fig. 8g) . If NUB1L binds to the Rpn1 subunit, it may act like a soluble 'FAT10-receptor' , and transfer-bound FAT10 and its conjugated substrates to the hRpn10 subunit of the proteasome to be degraded faster (Fig. 8g, transfer model) . Alternatively, NUB1L binding to Rpn1 could induce a conformational change in the hRpn10 subunit (Fig. 8g, facilitator model) , which allows FAT10 and its conjugated substrates to be more rapidly degraded.
Methods
Yeast strains and plasmids. Yeast strains and plasmid cloning are described in Supplementary Tables S1 and S2 , respectively.
GST-pull-down-assay. GST, GST-FAT10, GST-NUB1L, GST-NUB1L∆UBA, GST-NUB1L∆UBL (Supplementary Table S2 ) and His-hRpn10 (ref. 12) (kindly provided by Patrick Young, Stockholm University) were expressed in Escherichia coli strain B834(DE3)pLysS as described 32 . Glutathione sepharose 4B beads (GE Healthcare) were incubated with GST, GST-FAT10 or GST-NUB1L along with purified His-hRpn10 in incubation buffer (20 mM Tris-HCl, pH 7.4, 0.1% TritonX-100) overnight at 4 °C and washed 5 times with incubation buffer. For other experiments, His-hRpn10, His-UIM1 + UIM2 domains and His-VWA domain were in vitro transcribed and translated using TNT T7 coupled reticulocyte lysate system (Promega) and purified GST, GST-FAT10 or GST-NUB1L bound on the GSH beads was added. Proteins were eluted by boiling at 95 °C for 5 min with SDS buffer, resolved by SDS-PAGE and subjected to western blot analysis using anti-His antibody (1 µg ml − 1 , Sigma) or autoradiography. 
